Sources | Names Used |
---|---|
GDSC1000 | KIN001-260 |
PharmacoGx | KIN001-260 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ACSL4 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.006 |
mRNA | ACSS1 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.03 |
mRNA | ACTN4 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.07 |
mRNA | ACTR1A | GDSC1000 | pan-cancer | AAC | -0.062 | 0.05 |
mRNA | ACVR1 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.09 |
mRNA | ACY3 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0007 |
mRNA | ADAM11 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.009 |
mRNA | ADAM2 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.06 |
mRNA | ADAM32 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.08 |
mRNA | ADAMDEC1 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.002 |